Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1

Journal of Surgical Research

Volumn 82, Issue 2, 1999, Pages 156-162

  Fernandez, Harold A ^a   Kallenbach, Klaus ^a   Seghezzi, Graziano ^a   Grossi, Eugene ^a   Colvin, Stephen ^a   Schneider, Robert ^a   Mignatti, Paolo ^a   Galloway, Aubrey ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Angiogenesis; Boyden chamber; Extracellular matrix; Invasion; Migration; MMP; TIMP 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CELL MIGRATION; ENDOTHELIUM CELL; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

EID: 0032816628     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5534     Document Type: Article

References (31)

1. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 73:1993;161.
2. Vincenti M. P., Coon C. I., Lee O., Brinckerhoff C. E. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res. 22:1994;4818.
3. Herron G. S., Banda M. J., Clark E. J., Gavrilovic J., Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem. 261:1986;2814.
4. Welgus H. G., Jeffrey J. J., Eisen A. Z., Roswit W. T., Stricklin G. P. Human skin fibroblast collagenase: Interaction with substrate and inhibitor. Coll. Relat. Res. 5:1985;167.
5. Walther S. E., Denhardt D. T. Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity. Cell Growth Differ. 7:1996;1579.
6. Cornelius L. A., Nehring L. C., Roby J. D., Parks W. C., Welgus H. G. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105:1995;170.
7. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;189.
8. Mignatti P., Rifkin D. B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein. 49:1996;117.
9. Battegay E. J. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. 73:1995;333.
10. Folkman J., Merler E., Abernathy C., Williams G. Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133:1971;275.
11. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58.
12. Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14:1977;53.
13. Pepper M. S., Montesano R., Mandriota S. J., Orci L., Vassalli J. D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 49:1996;138.
14. Kawamata H., Kawai K., Kameyama S., Johnson M. D., Stetler-Stevenson W. G., Oyasu R. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int. J. Cancer. 63:1995;680.
15. Mohanam S., Wang S. W., Rayford A., Yamamoto M., Sawaya R., Nakajima M., Liotta L. A., Nicolson G. L., Stetler-Stevenson W. G., Rao J. S. Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasionin vivo. Clin. Exp. Metastasis. 13:1995;57.
16. Thorgeirsson U. P., Yoshiji H., Sinha C. C., Gomez D. E. Breast cancer: Tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis. In Vivo. 10:1996;137.
17. Anand-Apte B., Pepper M. S., Voest E., Montesano R., Olsen B., Murphy G., Apte S. S., Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38:1997;817.
18. Khokha R., Zimmer M. J., Graham C. H., Lala P. K., Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst. 84:1992;1017.
19. Alexander C. M., Werb Z. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cellsin vitro. J. Cell Biol. 118:1992;727.
20. Lemarchand P., Jaffe H. A., Danel C., Cid M. C., Kleinman H. K., Stratford-Perricaudet L. D., Perricaudet M., Pavirani A., Lecocq J. P., Crystal R. G. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA. 89:1992;6482.
21. Thimmappaya B., Jones N., Shenk T. A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell. 18:1979;947.
22. Sambrook L. J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
23. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59.
24. Docherty A. J., Lyons A., Smith B. J., Wright E. M., Stephens P. E., Harris T. J., Murphy G., Reynolds J. J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 318:1985;66.
25. Ausubel F., Brent R., Kingston R., Moore D., Seidman J., Smith J., Struhl K. Short Protocols in Molecular Biology. 1992;Greene Publishing and Wiley, New York.
26. Lemarchand P., Jones M., Yamada I., Crystal R. G. In vivo. Circ. Res. 72:1993;1132.
27. Berkner K. L. Expression of heterologous sequences in adenoviral vectors. Curr. Topics Microbiol. Immunol. 158:1992;39.
28. Mignatti P., Tsuboi R., Robbins E., Rifkin D. B. In vitro. J. Cell Biol. 108:1989;671.
29. Terranova V. P., Hujanen E. S., Loeb D. M., Martin G. R., Thornburg L., Glushko V. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Natl. Acad. Sci. USA. 83:1986;465.
30. Anand-Apte B., Bao L., Smith R., Iwata K., Olsen B. R., Zetter B., Apte S. S. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem. Cell Biol. 74:1996;853.
31. Zempo N., Koyama N., Kenagy R. D., Lea H. J., Clowes A. W. Regulation of vascular smooth muscle cell migration and proliferationin vitro. Arterioscler. Thromb. Vasc. Biol. 16:1996;28.